Results 131 to 140 of about 23,984,619 (356)

A Novel Encrypt Methods of Markov Models

, 2019
G. Kavitha, S Theivasigamani, S. Amudha, A Kumarave, K Rangarajan, P Kavitha, S Prabakaran, A Kumaravel, O Meetei, A Kumarave, K Rangarajan, P Kavitha, S Prabakaran, P Dutta, A Kumaravel, A Kumaravel, P Dutta, A Kumaravel, K Rangarajan, P Kavitha, S Prabakaran, A Kumaravel, J Tariq, A Kumaravel, M Sudha, A Kumaravel, G Ayyappan, C Nalini, A Kumaravel, K Kaliyamurthie, K Sivaraman, S Ramesh, K Kaliyamurthie, P Balasubramanian, A Sangeetha, C Nalini, S Gayathiridevi, C Nalini, N Kumar, C Nalini, Shwtambarikharabe, M Vivekanandan, Dr Rajabhushanam, Dr, V Rajabhushanam, G Karthik, Vivek, K Rangaswamy, Dr Rajabhushanamc, R Kavitha, R Nedunchelian, G Kavitha, R Kavitha, G Kavitha, R Kavitha, G Michael, A Chandrasekar, G Michael, A Chandrasekar, S Pothumani, M Sriram, J Sridhar, G Arul Selvan, S Pothumani, M Sriram, Sridhar, S Pothumani, M Sriram, Sridhar, N Priya, J Sridhar, M Sriram, N Priya, J Sridhar, M Sriram, N Priya, J Sridhar, M Sriram, Anuradha, Khanna, Anuradha, Khanna, Anuradha, Khanna, B Sundarraj, K Kaliyamurthie, B Sundarraj, K Kaliyamurthie, B Sundarraj, K Kaliyamurthie, K Sivaraman, M Senthil, K Sivaraman, K Kaliyamurthie, K Sivaraman, V Khanna   +95 more
openalex   +1 more source

Regional Shopping Objectives in British Grocery Retail Transactions Using Segmented Topic Models

Applied Stochastic Models in Business and Industry, EarlyView.
ABSTRACT Understanding the customer behaviours behind transactional data has high commercial value in the grocery retail industry. Customers generate millions of transactions every day, choosing and buying products to satisfy specific shopping needs.
Mariflor Vega Carrasco, Mirco Musolesi, Jason O'Sullivan, Rosie Prior, Ioanna Manolopoulou   +4 more
wiley   +1 more source

Improving on hidden Markov models: An articulatorily constrained, maximum likelihood approach to speech recognition and speech coding

, 1996
John Hogden
openalex   +2 more sources

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Subject-driven supervised and unsupervised Hidden Markov Models for heart sound segmentation in real noisy environments

, 2018
Jorge Oliveira
openalex   +2 more sources

A new sampling capability for uncertainty quantification in the Ice-sheet and Sea-level System Model v4.19 using Gaussian Markov random fields -- Datasets and results

, 2021
Kevin Bulthuis, Eric Larour
openalex   +2 more sources

Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Population pharmacokinetic (popPK) and pharmacokinetic‐pharmacodynamic (PK/PD) models were developed to support clinical development of nemolizumab, a humanized monoclonal antibody targeting the IL‐31 receptor α, in adolescents and adults with moderate‐to‐severe atopic dermatitis (AD).
Floris Fauchet, Anna Largajolli, Petra M. Jauslin, Emilie Schindler, Mourad Hamimed, Wannee Kantasiripitak, Antonio Gonçalves, Eline Van Maanen, Khaled Benkali, Tomohisa Saito, Jonathan I. Silverberg, Andreas Wollenberg, Michael Graeber, Liliana Ulianov, Christophe Piketty, Luca Loprete, Vincent Duval, Nathalie Wagner   +17 more
wiley   +1 more source

Learning Dependencies of Discrete Speech Representations with Neural Hidden Markov Models [PDF]

, 2022
Sung-Lin Yeh, Hao Tang
openalex   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Prioritizing Feasible and Impactful Actions to Enable Secure AI Development and Use in Biology

Biotechnology and Bioengineering, EarlyView.
ABSTRACT As artificial intelligence continues to enhance biological innovation, the potential for misuse must be addressed to fully unlock the potential societal benefits. While significant work has been done to evaluate general‐purpose AI and specialized biological design tools (BDTs) for biothreat creation risks, actionable steps to mitigate the risk
Josh Dettman, Emily Lathrop, Aurelia Attal‐Juncqua, Matthew Nicotra, Allison Berke   +4 more
wiley   +1 more source